PT Sentra Asia Gemilang (Indonesia)

Sentra Asia Gemilang is primarily engaged in pharmaceuticals activity. Its headquarters is located in Dki Jakarta. The company was founded in 2001. Sentra Asia Gemilang was established by a group of visionary entrepreneurs with a mission to enhance healthcare accessibility and quality in Indonesia. The company focuses on the development, manufacturing, and distribution of a wide range of pharmaceutical products, including prescription medications, over-the-counter drugs, and health supplements. As a key player in the Indonesian pharmaceutical industry, Sentra Asia Gemilang operates several branches across major cities in Indonesia, ensuring a robust local geographical footprint. The company is committed to expanding its reach and currently exports its products to several Southeast Asian countries, contributing to its growing global presence. Sentra Asia Gemilang's product portfolio includes well-known brands that cater to various therapeutic areas such as cardiovascular health, diabetes management, and respiratory care. The company is dedicated to research and development, continuously innovating to introduce new and effective healthcare solutions. In collaboration with international pharmaceutical firms, Sentra Asia Gemilang engages in joint ventures to enhance its product offerings and technological capabilities. The company is a member of several industry associations, actively participating in initiatives to improve healthcare standards and regulations. With a vision to become a leading pharmaceutical company in the region, Sentra Asia Gemilang is committed to delivering high-quality, affordable healthcare products. The company's mission is to improve the well-being of communities by providing innovative and accessible healthcare solutions.